Skip to content
10-Q

Quarterly Report

GENOMIC HEALTH, INC.

0001558370-18-009041

← back to feed
Filed
Nov 8, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · Oct 31, 2018 36.12M sh
Cash And Equivalents Q3 2018 · Sep 30, 2018 $69.24M
Cash And Equivalents Q3 2018 · Dec 31, 2017 $45.52M
Current Liabilities Q3 2018 · Sep 30, 2018 $50.41M
Current Liabilities Q3 2018 · Dec 31, 2017 $39.52M
Current Assets Q3 2018 · Sep 30, 2018 $246.7M
Current Assets Q3 2018 · Dec 31, 2017 $174.26M
Total Assets Q3 2018 · Sep 30, 2018 $300.37M
Total Assets Q3 2018 · Dec 31, 2017 $231.62M
Shares Diluted Q3 2018 · Sep 30, 2017 34.68M sh
Shares Diluted Q3 2018 · Sep 30, 2017 34.37M sh
Capex Q3 2018 · Sep 30, 2017 $10.4M
Operating Cash Flow restated Q3 2018 · Sep 30, 2017 $21.47M
Eps Diluted Q3 2018 · Sep 30, 2017 −$0.06
Eps Diluted Q3 2018 · Sep 30, 2017 −$0.17
Eps Basic Q3 2018 · Sep 30, 2017 −$0.06
Eps Basic Q3 2018 · Sep 30, 2017 −$0.17
Sga Expense Q3 2018 · Sep 30, 2017 $17.51M
Sga Expense Q3 2018 · Sep 30, 2017 $52.65M
Rd Expense Q3 2018 · Sep 30, 2017 $17.21M
Rd Expense Q3 2018 · Sep 30, 2017 $47.87M
Net Income Q3 2018 · Sep 30, 2017 −$2.19M
Net Income Q3 2018 · Sep 30, 2017 −$5.74M
Operating Income Q3 2018 · Sep 30, 2017 −$2.63M
Operating Income Q3 2018 · Sep 30, 2017 −$8.6M
Cost Of Revenue Q3 2018 · Sep 30, 2017 $13.43M
Cost Of Revenue Q3 2018 · Sep 30, 2017 $40.9M